AstraZeneca PLC

67.44+0.1800+0.27%Vol 1.84M1Y Perf 1.88%
Mar 24th, 2023 11:35 DELAYED
BID67.43 ASK67.44
Open67.73 Previous Close67.26
Pre-Market67.74 After-Market-
 0.48 0.71%  - -
Target Price
77.30 
Analyst Rating
Strong Buy 1.50
Potential %
14.71 
Finscreener Ranking
+     37.96
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     28.23
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     48.50
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
     21.73
Price Range Ratio 52W %
75.96 
Earnings Rating
Sell
Market Cap209.04B 
Earnings Date
5th May 2023
Alpha0.01 Standard Deviation0.06
Beta0.44 

Today's Price Range

67.0867.79

52W Range

52.6572.12

5 Year PE Ratio Range

18.50119.80

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.51%
1 Month
1.34%
3 Months
-1.06%
6 Months
23.23%
1 Year
1.88%
3 Years
64.49%
5 Years
96.84%
10 Years
202.30%

TickerPriceChg.Chg.%
AZN67.440.18000.27
AAPL158.39-0.5400-0.34
GOOG105.54-0.7200-0.68
MSFT277.32-0.3400-0.12
XOM102.34-1.0700-1.03
WFC35.44-1.1700-3.20
JNJ151.480.35000.23
FB196.640.99000.51
GE91.10-0.4900-0.53
JPM123.57-3.2700-2.58
 
ProfitabilityValueIndustryS&P 500US Markets
68.70
5.30
19.00
6.90
7.21
RevenueValueIndustryS&P 500US Markets
36.54B
11.79
16.49
9.31
DividendsValueIndustryS&P 500US Markets
1.28
0.91
0.24
0.11
Payout ratio93.00
Earnings HistoryEstimateReportedSurprise %
Q04 20220.680.691.47
Q03 20220.770.849.09
Q02 20220.780.8610.26
Q01 20220.860.9510.47
Q04 20210.770.849.09
Q03 20210.630.54-14.29
Q02 20210.450.450.00
Q01 20210.710.8114.08
Earnings Per EndEstimateRevision %Trend
12/2022 QR0.71-11.25Negative
12/2022 FY3.33-8.77Negative
3/2023 QR0.88-73.41Negative
12/2023 FY3.64--
Next Report Date5th May 2023
Estimated EPS Next Report0.84
Estimates Count4
EPS Growth Next 5 Years %14.70
Volume Overview
Volume1.84M
Shares Outstanding3.10M
Shares Float3.10B
Trades Count23.09K
Dollar Volume123.83M
Avg. Volume4.47M
Avg. Weekly Volume4.17M
Avg. Monthly Volume4.24M
Avg. Quarterly Volume5.00M

AstraZeneca PLC (NYSE: AZN) stock closed at 67.26 per share at the end of the most recent trading day (a 1.04% change compared to the prior day closing price) with a volume of 4.31M shares and market capitalization of 209.04B. Is a component of NASDAQ 100 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 76100 people. AstraZeneca PLC CEO is Pascal Soriot.

The one-year performance of AstraZeneca PLC stock is 1.88%, while year-to-date (YTD) performance is -0.8%. AZN stock has a five-year performance of 96.84%. Its 52-week range is between 52.65 and 72.12, which gives AZN stock a 52-week price range ratio of 75.96%

AstraZeneca PLC currently has a PE ratio of 101.70, a price-to-book (PB) ratio of 6.06, a price-to-sale (PS) ratio of 6.01, a price to cashflow ratio of 24.30, a PEG ratio of 2.32, a ROA of 2.21%, a ROC of 4.10% and a ROE of 5.93%. The company’s profit margin is 7.21%, its EBITDA margin is 19.00%, and its revenue ttm is $36.54 Billion , which makes it $11.79 revenue per share.

Of the last four earnings reports from AstraZeneca PLC, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.84 for the next earnings report. AstraZeneca PLC’s next earnings report date is 05th May 2023.

The consensus rating of Wall Street analysts for AstraZeneca PLC is Strong Buy (1.5), with a target price of $77.3, which is +14.71% compared to the current price. The earnings rating for AstraZeneca PLC stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AstraZeneca PLC has a dividend yield of 1.28% with a dividend per share of $0.91 and a payout ratio of 93.00%.

AstraZeneca PLC has a Buy technical analysis rating based on Technical Indicators (ADX : 8.53, ATR14 : 1.10, CCI20 : 153.34, Chaikin Money Flow : 0.08, MACD : -0.03, Money Flow Index : 59.11, ROC : 4.62, RSI : 57.13, STOCH (14,3) : 85.75, STOCH RSI : 1.00, UO : 60.67, Williams %R : -14.25), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AstraZeneca PLC in the last 12-months were: Andreas Rummelt (Sold 7 585 shares of value $989 539 ), Aradhana Sarin (Sold 25 403 shares of value $3 313 401 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (75.00 %)
6 (75.00 %)
5 (71.43 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (25.00 %)
2 (25.00 %)
2 (28.57 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.57

AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

CEO: Pascal Soriot

Telephone: +44 2037495000

Address: 1 Francis Crick Avenue, Cambridge CB2 0AA, , GB

Number of employees: 76 100

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

57%43%

Bearish Bullish

58%42%

TipRanks News for AZN

Fri, 10 Mar 2023 21:15 GMT AstraZeneca (AZN) Receives a Buy from SVB Securities

- TipRanks. All rights reserved.

Fri, 10 Feb 2023 12:30 GMT Analysts Are Bullish on Top Healthcare Stocks: AstraZeneca (AZN), AbbVie (ABBV)

- TipRanks. All rights reserved.

News

Stocktwits